Search Results for "Sng001"
Synairgen Plc is in talks with potential partners following the results of a study of an experimental medicine targeting infections that trigger asthma attacks, Chief Executive Officer Richard Marsd...
Synairgen (LON:SNG) has raised £2.5 million through a placing to advance the progress of its asthma drug, it was revealed. It comes after the firm announced in April positive data from its Phas...
Matching PubMed Articles